// App-Quantinova.ai

971 : Efficacy of an Anti-CD22 Antibody-Monomethyl Auristatin E Conjugate in a Preclinical Xenograft Model of Precursor B Cell Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Sakiko Yoshida

Principal Investigators

  • Emily Tuscano

  • Connie Duong

  • Joseph Tuscano

  • Noriko Satake

Medical Centers

  • Pediatrics, UC Davis, Sacramento, CA

  • Hematology/Oncology, UC Davis Cancer Center, Sacramento, CA

  • UC Davis, Sacramento, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B cell lymphomas

  • Mismatch repair deficiency

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • Translocator protein

Drug/Treatment

  • monomethyl auristatin E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved